General Information of the Compound
Compound ID |
CP0476439
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2S)-2-((4R)-4-((3R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)-5-oxo-5-(m-tolylamino)pentanoate
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C36H54N2O6
|
||||||||||||||||||
Molecular Weight |
610.836
|
||||||||||||||||||
Canonical SMILES |
C[C@H](CCC(=O)N[C@@H](CCC(=O)Nc1cccc(C)c1)C(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C36H54N2O6/c1-21-6-5-7-24(18-21)37-31(41)13-11-29(34(43)44)38-32(42)12-8-22(2)26-9-10-27-33-28(15-17-36(26,27)4)35(3)16-14-25(39)19-23(35)20-30(33)40/h5-7,18,22-23,25-30,33,39-40H,8-17,19-20H2,1-4H3,(H,37,41)(H,38,42)(H,43,44)/t22-,23-,25-,26-,27+,28+,29+,30-,33+,35+,36-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
IWMUINPHRXSQCK-JJBSANDOSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound